Infective Endocarditis: a Case Series
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Myocarditis and Cardiomyopathy
CE: Tripti; HCO/330310; Total nos of Pages: 6; HCO 330310 REVIEW CURRENT OPINION Myocarditis and cardiomyopathy Jonathan Buggey and Chantal A. ElAmm Purpose of review The aim of this study is to summarize the literature describing the pathogenesis, diagnosis and management of cardiomyopathy related to myocarditis. Recent findings Myocarditis has a variety of causes and a heterogeneous clinical presentation with potentially life- threatening complications. About one-third of patients will develop a dilated cardiomyopathy and the pathogenesis is a multiphase, mutlicompartment process that involves immune activation, including innate immune system triggered proinflammatory cytokines and autoantibodies. In recent years, diagnosis has been aided by advancements in cardiac MRI, and in particular T1 and T2 mapping sequences. In certain clinical situations, endomyocardial biopsy (EMB) should be performed, with consideration of left ventricular sampling, for an accurate diagnosis that may aid treatment and prognostication. Summary Although overall myocarditis accounts for a minority of cardiomyopathy and heart failure presentations, the clinical presentation is variable and the pathophysiology of myocardial damage is unique. Cardiac MRI has significantly improved diagnostic abilities, but endomyocardial biopsy remains the gold standard. However, current treatment strategies are still focused on routine heart failure pharmacotherapies and supportive care or cardiac transplantation/mechanical support for those with end-stage heart failure. Keywords cardiac MRI, cardiomyopathy, endomyocardial biopsy, myocarditis INTRODUCTION prevalence seen in children and young adults aged Myocarditis refers to inflammation of the myocar- 20–30 years [1]. dium and may be caused by infectious agents, systemic diseases, drugs and toxins, with viral infec- CAUSE tions remaining the most common cause in the developed countries [1]. -
CASE REPORTS Supraventricular Tachycardia As the Initial
http://crim.sciedupress.com Case Reports in Internal Medicine, 2015, Vol. 2, No. 3 CASE REPORTS Supraventricular tachycardia as the initial presentation of bacterial infective endocarditis: A rare case report Wei-Tsung Wu1, Hung-Ling Huang2, Ho-Ming Su1, 3, Tsung-Hsien Lin1, 3, Kun-Tai Lee1, 3, Sheng-Hsiung Sheu1, 3, Po-Chao Hsu1, 3 1. Division of Cardiology, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan, ROC. 2. Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan, ROC. 3. Department of Internal Medicine, Faculty of Medicine, School of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan, ROC Correspondence: Po-Chao Hsu. Address: Division of Cardiology, Department of Internal Medicine, Kaohsiung Medical University Hospital, 100 Tzyou 1st Road, Kaohsiung. 80708, Taiwan, ROC. Email: [email protected] Received: May 19, 2015 Accepted: June 15, 2015 Online Published: June 17, 2015 DOI: 10.5430/crim.v2n3p26 URL: http://dx.doi.org/10.5430/crim.v2n3p26 Abstract Infective endocarditis (IE) is an infection of the heart valves or the heart’s inner lining. The clinical symptoms of infectious endocarditis vary considerably, some are subtle and non-specific, which make the diagnosis difficult or the signs misleading. In some cases cardiac symptoms are associated with intra cardiac extension of the infection, including murmur, conduction blocks and congestive heart failure. However, there was no literature description of supraventricular tachycardia (SVT) as the initial presentation of IE. Herein we report a case of bacterial IE with SVT as the initial presentation of disease, which finally leaded to catastrophic outcome. -
Myocarditis, Pericarditis and Other Pericardial Diseases
Heart 2000;84:449–454 Diagnosis is easiest during epidemics of cox- GENERAL CARDIOLOGY sackie infections but diYcult in isolated cases. Heart: first published as 10.1136/heart.84.4.449 on 1 October 2000. Downloaded from These are not seen by cardiologists unless they develop arrhythmia, collapse or suVer chest Myocarditis, pericarditis and other pain, the majority being dealt with in the primary care system. pericardial diseases Acute onset of chest pain is usual and may mimic myocardial infarction or be associated 449 Celia M Oakley with pericarditis. Arrhythmias or conduction Imperial College School of Medicine, Hammersmith Hospital, disturbances may be life threatening despite London, UK only mild focal injury, whereas more wide- spread inflammation is necessary before car- diac dysfunction is suYcient to cause symp- his article discusses the diagnosis and toms. management of myocarditis and peri- Tcarditis (both acute and recurrent), as Investigations well as other pericardial diseases. The ECG may show sinus tachycardia, focal or generalised abnormality, ST segment eleva- tion, fascicular blocks or atrioventricular con- Myocarditis duction disturbances. Although the ECG abnormalities are non-specific, the ECG has Myocarditis is the term used to indicate acute the virtue of drawing attention to the heart and infective, toxic or autoimmune inflammation of leading to echocardiographic and other investi- the heart. Reversible toxic myocarditis occurs gations. Echocardiography may reveal segmen- in diphtheria and sometimes in infective endo- -
Myocarditis, Pericarditis Cardiomyopathies
Endocarditis, myocarditis, pericarditis. Cardiomyopathies Attila Zalatnai Endocarditis: inflammation of the endocardium, especially the valves 1. Infective endocarditis: (bacteria, fungi) Predisposing factors: - septicemia - valve malformations - deformed, calcified valves - arteficial valve implantation - previous rheumatic fever - peridontal, periapical foci! Most important causative agents: Strcc. viridans Enterococcus (Str. fecalis) Staphylococcus aureus Candida species Morphology: Vegetations Valve destruction Both Complications: embolization (septic emboli, septic abscesses) sepsis „mycotic aneurysms”, subarachnoidal hemorrhage acute left sided heart failure (regurgitation, chorda tendinea rupture) healing by scarring and calcification VITIUM stenosis insufficiency combined 2. Non-infective endocarditis: verrucous endocarditis (rheumatic fever) SLE (Libman-Sacks endocarditis) – atypical „marantic” endocarditis - paraneoplastic Myocarditis: an inflammatory infiltrate (helper T-cells, macrophages) of the myocardium with necrosis and/or degeneration of adjacent myocytes Genetic and environmental disposition + causative mechanisms Direct cytotoxic Aberrant effect of infectious induction of causative agents apoptosis Cytokine expression in the myocardium Secondary autoimmune (TNF-alpha, NOS) mechanisms Etiology of the myocarditis - I. Infectious origin - VIRUSES (Coxsackie B, enterovirus, influenza, CMV, EBV, HSV… Coxsackie A9 – self limiting disease; Coxsackie B3 – severe, sometimes lethal) - bacteria (Diphtheria, tbc, clostridia, staphylococci, -
Currentstateofknowledgeonaetiol
European Heart Journal (2013) 34, 2636–2648 ESC REPORT doi:10.1093/eurheartj/eht210 Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases Downloaded from Alida L. P. Caforio1†*, Sabine Pankuweit2†, Eloisa Arbustini3, Cristina Basso4, Juan Gimeno-Blanes5,StephanB.Felix6,MichaelFu7,TiinaHelio¨ 8, Stephane Heymans9, http://eurheartj.oxfordjournals.org/ Roland Jahns10,KarinKlingel11, Ales Linhart12, Bernhard Maisch2, William McKenna13, Jens Mogensen14, Yigal M. Pinto15,ArsenRistic16, Heinz-Peter Schultheiss17, Hubert Seggewiss18, Luigi Tavazzi19,GaetanoThiene4,AliYilmaz20, Philippe Charron21,andPerryM.Elliott13 1Division of Cardiology, Department of Cardiological Thoracic and Vascular Sciences, University of Padua, Padova, Italy; 2Universita¨tsklinikum Gießen und Marburg GmbH, Standort Marburg, Klinik fu¨r Kardiologie, Marburg, Germany; 3Academic Hospital IRCCS Foundation Policlinico, San Matteo, Pavia, Italy; 4Cardiovascular Pathology, Department of Cardiological Thoracic and Vascular Sciences, University of Padua, Padova, Italy; 5Servicio de Cardiologia, Hospital U. Virgen de Arrixaca Ctra. Murcia-Cartagena s/n, El Palmar, Spain; 6Medizinische Klinik B, University of Greifswald, Greifswald, Germany; 7Department of Medicine, Heart Failure Unit, Sahlgrenska Hospital, University of Go¨teborg, Go¨teborg, Sweden; 8Division of Cardiology, Helsinki University Central Hospital, Heart & Lung Centre, -
Neuropsychiatric Manifestations of Infective Endocarditis: a Study of 95 Patients at Ibadan, Nigeria
J Neurol Neurosurg Psychiatry: first published as 10.1136/jnnp.39.4.325 on 1 April 1976. Downloaded from Journal of Neurology, Neurosurgery, and Psychiatry, 1976, 39, 325-329 Neuropsychiatric manifestations of infective endocarditis: a study of 95 patients at Ibadan, Nigeria 0. BADEMOSI,1 A. 0. FALASE, F. JAIYESIMI, AND A. BADEMOSI From the Departments of Medicine and Paediatrics, University College Hospital, Ibadan, Nigeria SYNOPSIS Thirty-eight percent of patients with infective endocarditis (36 of 95) had neuropsychi- atric manifestations. In 750 (27 of 36), these features were the major presenting picture. Fifteen patients (42%) presented with cerebrovascular lesions and seven (19%) with meningitis. Toxic encephalopathy (12.5%) was not uncommon. Other neurological syndromes seen included psychosis and spinal cord lesions. The mortality was high especially when the infective endocarditis was acute in onset. It is essential to search diligently for an underlying cardiac cause in patients who present with neuropsychiatric symptoms because treatment of the underlying pathology improves prognosis. Although the clinical features of infective endo- criteria: (1) repeated positive blood cultures during a Protected by copyright. carditis are well established, significant changes febrile illness in a patient with known previous have taken place in the pattern of the disease in valvular or congenital heart disease; (2) evidence of the developed countries over the last 20 years peripheral manifestations of infective endocarditis; 1951; Pankey, (3) development of a significant cardiac murmur (Horder, 1909; Cates and Christie, with features of cardiac failure in any patient 1961, 1962; Thompson, 1964; Cooper et al., admitted for an unexplained febrile illness while 1966; British Medical Journal, 1973). -
Lyme Carditis and Sudden Cardiac Death
Health Update August 6, 2018 TO: Health Care Providers FROM: Mark Levine, MD, Commissioner of Health Lyme Carditis and Sudden CardiaC Death – Please Distribute as Appropriate – Laboratory results from the Centers for Disease Control and Prevention (CDC) have confirmed that the recent death of a Franklin County resident was a result of Lyme carditis, a rare complication of Lyme disease. This is the first reported death due to Lyme carditis in Vermont. Between 1985 and 2014 there were nine deaths related to Lyme carditis reported worldwide. The Health Department issued a Health Advisory on December 13, 2013 following a CDC report about sudden cardiac death associated with Lyme carditis. Symptomatic infection of the heart is rare in recognized Lyme disease cases. Approximately 1 percent of reported cases have Lyme carditis, which is usually present with other features of Lyme disease but can be observed independently. It is more common among males than would be expected based on the gender distribution of patients with clinical manifestations of Lyme disease. • Vermont Health Advisory: http://www.healthvermont.gov/dec2013_healthadvisory • CDC report: http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6249a1.htm?s_cid=mm6249a1_w The most common cardiac manifestation is atrioventricular block (first, second, or third degree). Symptoms of atrioventricular block include lightheadedness, palpitations, shortness of breath, chest pain and syncope. Some cases might require temporary pacing, although prognosis is excellent with appropriate antibiotic therapy. Lyme disease is endemic in Vermont. Place carditis symptoms in context during the spring, summer and fall seasons. Actions Requested: • If you suspect Lyme disease, treat with antibiotics according to current treatment guidelines: https://www.cdc.gov/lyme/treatment/index.html • Ask all patients with suspected Lyme disease about cardiac symptoms. -
The Frequency of Rhythm and Conduction Abnormalities and Benefits of 24-Hour Holter Electrocardiogram on Detecting These Abnormalities
ORIGINAL ARTICLE East J Med 24(3): 303-309, 2019 DOI: 10.5505/ejm.2019.31932 The Frequency of Rhythm and Conduction Abnormalities and Benefits of 24-Hour Holter Electrocardiogram on Detecting These Abnormalities In Patients With Acute Rheumatic Fever Serdar Epçaçan*, Yasemin Nuran Dönmez University of Health Sciences, Van Training and Research Hospital, Department of Pediatric Cardiology, Van, Turkey ABSTRACT During the acute phase of acute rheumatic fever (ARF), cardiac arrhythmias and conduction disorders may occur. Standard electrocardiogram (ECG) may be insufficient in the cases of possible paroxysmal rhythm or conduction abnormalities. The aim of this study is to evaluate arrhythmias and conduction disorders and benefits of 24-hour Holter ECG on detecting these disorders in children with ARF. Two hundred and ten patients who were diagnosed with ARF during a four-year period, were retrospectively analyzed. Demographic characteristics, clinical, laboratory, and echocardiographic findings of the patients were evaluated. Standard ECG and 24-hour Holter analysis were examined. First (47.8%), second (6.9%) and third degree (4.3%) atrioventricular (AV) blocks, bundle branch blocks (9.8%), intermittent pre-excitation (1.1%), accelerated nodal rhythm (15.2%), supraventricular (10.9%) and ventricular premature contractions (8.7%), as well as supraventricular (3.3%) and ventricular tachycardia (1.1%) were detected with 24 -hour Holter ECG. Frequency of both rhythm and conduction abnormalities were detected higher with Holter ECG than 12-lead ECG, and this was statistically significant (p<0.05). Second degree type II AV block and non-sustained supraventricular tachycardia as well as intermittent complete AV block were detected on 24-hour Holter analysis in patients with normal initial standard ECG. -
Long QT Syndrome: an Emerging Role for Inflammation and Immunity
REVIEWS IN MEDICINE published: 27 May 2015 doi: 10.3389/fcvm.2015.00026 Long QT syndrome: an emerging role for inflammation and immunity Pietro Enea Lazzerini*, Pier Leopoldo Capecchi and Franco Laghi-Pasini Department of Medical Sciences, Surgery and Neurosciences, University of Siena, Siena, Italy The long QT syndrome (LQTS), classified as congenital or acquired, is a multi-factorial disorder of myocardial repolarization predisposing to life-threatening ventricular arrhyth- mias, particularly torsades de pointes. In the latest years, inflammation and immunity have been increasingly recognized as novel factors crucially involved in modulating ventricular repolarization. In the present paper, we critically review the available information on this topic, also analyzing putative mechanisms and potential interplays with the other etiologic factors, either acquired or inherited. Accumulating data indicate inflammatory activation as a potential cause of acquired LQTS. The putative underlying mechanisms are complex but essentially cytokine-mediated, including both direct actions on cardiomyocyte ion channels expression and function, and indirect effects resulting from an increased Edited by: central nervous system sympathetic drive on the heart. Autoimmunity represents another Theofilos M. Kolettis, recently arising cause of acquired LQTS. Indeed, increasing evidence demonstrates that University of Ioannina, Greece autoantibodies may affect myocardial electric properties by directly cross-reacting with Reviewed by: Luigi Venetucci, the cardiomyocyte and interfering with specific ion currents as a result of molecular University of Manchester, UK mimicry mechanisms. Intriguingly, recent data suggest that inflammation and immunity Giannis G. Baltogiannis, Cardiovascular Institute, Greece may be also involved in modulating the clinical expression of congenital forms of LQTS, *Correspondence: possibly triggering or enhancing electrical instability in patients who already are genetically Pietro Enea Lazzerini, predisposed to arrhythmias. -
Lyme Carditis Presenting As Atrial Fibrillation Treated Successfully - 08-11-2019 by Dr
Lyme carditis presenting as atrial fibrillation treated successfully - 08-11-2019 by Dr. Daniel Cameron - Daniel Cameron, MD, MPH - http://danielcameronmd.com Lyme carditis presenting as atrial fibrillation treated successfully Sunday, August 11, 2019 http://danielcameronmd.com/lyme-carditis-atrial-fibrillation-treated-successfully/ A case study published in the British Medical Journal features a 23-year-old man with a history of degenerative joint disease who presented with a sudden onset of palpitations. [2] His echocardiogram (ECG) revealed atrial fibrillation (AF) with a mildly dilated left Atrium. The patient did not recall a tick bite or a rash. And, “Although Lyme carditis was on the differential diagnoses list, it was not considered high enough due to the initial rhythm being AF and not [atrioventricular ] AV block,” writes Shabbir and colleagues. The man was treated with metoprolol and released from the hospital after his heart spontaneously reverted back to normal sinus rhythm. However, 4 days later the patient returned to the hospital. “ECG now exhibited atrioventricular (AV) mobitz-II block alternating with intermittent complete heart block (CHB) on telemetry confirmed with ECG,” writes Shabbir. He was tested for Lyme disease and treated empirically with intravenous ceftriaxone. Within 48 hours, his symptoms began to improve. Lyme disease tests came back positive. And 1 month later, after antibiotic therapy, his heart rhythm had returned to normal. The authors' key learning points include: 1. Consider the unusual initial presentation of Lyme disease as atrial fibrillation. 2. Keeping Lyme carditis in the differential diagnoses when someone from a Lyme-endemic area presents as supraventricular arrhythmia (atrial fibrillation/flutter). -
Infective Endocarditis: a Focus on Oral Microbiota
microorganisms Review Infective Endocarditis: A Focus on Oral Microbiota Carmela Del Giudice 1 , Emanuele Vaia 1 , Daniela Liccardo 2, Federica Marzano 3, Alessandra Valletta 1, Gianrico Spagnuolo 1,4 , Nicola Ferrara 2,5, Carlo Rengo 6 , Alessandro Cannavo 2,* and Giuseppe Rengo 2,5 1 Department of Neurosciences, Reproductive and Odontostomatological Sciences, Federico II University of Naples, 80131 Naples, Italy; [email protected] (C.D.G.); [email protected] (E.V.); [email protected] (A.V.); [email protected] (G.S.) 2 Department of Translational Medical Sciences, Medicine Federico II University of Naples, 80131 Naples, Italy; [email protected] (D.L.); [email protected] (N.F.); [email protected] (G.R.) 3 Department of Advanced Biomedical Sciences, University of Naples Federico II, 80131 Naples, Italy; [email protected] 4 Institute of Dentistry, I. M. Sechenov First Moscow State Medical University, 119435 Moscow, Russia 5 Istituti Clinici Scientifici ICS-Maugeri, 82037 Telese Terme, Italy 6 Department of Prosthodontics and Dental Materials, School of Dental Medicine, University of Siena, 53100 Siena, Italy; [email protected] * Correspondence: [email protected]; Tel.: +39-0817463677 Abstract: Infective endocarditis (IE) is an inflammatory disease usually caused by bacteria entering the bloodstream and settling in the heart lining valves or blood vessels. Despite modern antimicrobial and surgical treatments, IE continues to cause substantial morbidity and mortality. Thus, primary Citation: Del Giudice, C.; Vaia, E.; prevention and enhanced diagnosis remain the most important strategies to fight this disease. In Liccardo, D.; Marzano, F.; Valletta, A.; this regard, it is worth noting that for over 50 years, oral microbiota has been considered one of the Spagnuolo, G.; Ferrara, N.; Rengo, C.; significant risk factors for IE. -
Infective Endocarditis
. Infective endocarditis Information for patients You may have recently been diagnosed or treated for a heart condition called infective endocarditis. Or you may wonder if you are at risk of this condition. This leaflet explains the causes and symptoms of infective endocarditis, and what to do if you have any. It describes treatments that you might have and how you should recover after treatment. This leaflet also has information on preventing an episode of infective endocarditis in the future. There is also a list of hospital contacts and sources of further information and support. What is infective endocarditis? Infective endocarditis is an infection of the inner lining or valves of the heart. It is caused by bacteria entering the bloodstream and sticking to heart structures. It is very rare, affecting 30 people in every one million each year. It can be serious, especially if complications develop. Early diagnosis, early antibiotic treatment and early surgery (if needed) are vital. Treatment requires hospital admission and a course of antibiotics through a drip. Up to 50% of patients may need surgery to repair or replace a damaged heart valve. In the most severe cases, the risk of death can be 1 in 5. What causes infective endocarditis? Your heart is usually well protected against infection and most bacteria pass by harmlessly. If your heart valves are damaged or you have an artificial valve, it is easier for bacteria to “sneak past” your normal immune defence and take root. This can mean that: • Bacteria – or occasionally fungi – settle on the inner lining of your heart (the endocardium).